Workflow
口服药物具备生物制剂样活性
icon
Search documents
Kymera Therapeutics (NasdaqGM:KYMR) FY Conference Transcript
2026-01-13 18:02
Kymera Therapeutics (NasdaqGM:KYMR) FY Conference January 13, 2026 12:00 PM ET Company ParticipantsNello Mainolfi - CEOConference Call ParticipantsNone - Analyst 2Brian Cheng - Senior Biotech AnalystNone - Analyst 1Brian ChengGood morning, everyone. Thanks for joining us for another session at the 44th J.P. Morgan Healthcare Conference. I'm Brian Chang. I'm one of the senior biotech analysts here at the firm. On stage, we have the CEO from Kymera Therapeutics, Nello Mainolfi. I'll now pass the mic to their ...